The Creative Process Behind my Homepage Redesign
I recently redesigned my homepage to better reflect my minimalist aesthetic and the central role of text in my work. The process led me to reflect on how different creative approaches—conceptual planning versus discovery through making—can each serve a purpose.
Beyond Approval: The Hidden Risk in Biotech Stocks
What happens after regulatory approval? The overlooked risks biotech companies face post-approval—and why even promising drugs can stumble after reaching the market.
How Public Speaking Taught Me to Stop Explaining and Start Connecting
A few months ago, I joined an English-speaking club in Munich – about an hour’s drive from where I live, just across the border. I’ve always loved stories and the ideas they carry. But despite that fascination, I found it difficult to speak
Mind the Gap: Bridging Drug and Device Thinking
A few months ago, I stepped into a new role – shifting from biologics development to device development within the same company. It’s been an exciting change and an opportunity to expand my perspective on pharmaceutical development. While bot
Tariff Shocks and Portfolio Lessons: Navigating Uncertainty in a Volatile Market
In early April, amid rising geopolitical tensions and economic uncertainty, I made the decision to reduce my exposure to certain consumer discretionary and tech stocks in my portfolio – one of them being Alphabet, the parent company of Google.
